- Reduced phosphodiesterase 3 activity and phosphodiesterase 3A level in synthetic vascular smooth muscle cells: implications for use of phosphodiesterase 3 inhibitors in cardiovascular tissues. Dunkerley, H.A., Tilley, D.G., Palmer, D., Liu, H., Jimmo, S.L., Maurice, D.H. Mol. Pharmacol. (2002)









